NCT01517516 Multi Modal Imaging: An MRI Study to Investigate Differences in the Structure and the Function of the Brain at Rest. Status COMPLETED Phase N/A
NCT01514240 Phase III Study of D9421-C 9 mg in Patients With Active Crohn's Disease in Japan Status COMPLETED Phase PHASE3
NCT01510431 Safety and Treatment Outcome Study of PROCHYMAL® (Remestemcel-L) Intravenous Infusion in Subjects With Treatment-resistant Crohn's Disease Status NO_LONGER_AVAILABLE Phase N/A
NCT01505855 Efficacy Study of Pneumococcal Vaccination in Crohn's Disease Status COMPLETED Phase PHASE4
NCT01503099 Intestinal Tuberculosis Diagnostics and the Differentiation From Crohn's Disease Status UNKNOWN Phase N/A
NCT01496053 Anti-inflammatory Effect of Agaricus Blazei Murill in Inflammatory Bowel Disease (IBD) Status COMPLETED Phase PHASE2/PHASE3
NCT01489943 A Study to Investigate the Effect of GSK1605786 on Hepatic Cytochrome P450, and BCRP and OATP1B1 Transport in Healthy Adult Subjects Status COMPLETED Phase PHASE1
NCT01470599 A Open-Label Study Of CP-690,550 As Long-Term Therapy (48 Weeks) In Subjects With Crohn's Disease Status COMPLETED Phase PHASE2
NCT01468090 Disease Course in an IBD Cohort in the Era of Biological Treatment Status COMPLETED Phase N/A
NCT01466374 Induction and Maintenance Study of BMS-936557 in Patients With Moderate to Severely Active Crohn's Disease Status COMPLETED Phase PHASE2
NCT01464333 Special Investigation (Long-term Investigation) in Patients With Crohn's Disease Status COMPLETED Phase N/A
NCT01453946 Safety and Maintenance Study of Entocort for Children With Crohn's Disease Status COMPLETED Phase PHASE3
NCT01442025 Study Investigating Tailored Treatment With Infliximab for Active Crohn's Disease Status COMPLETED Phase PHASE4
NCT01438151 Understanding the Relationship Between Infliximab Levels to Clinical Response of Remicade in Crohn's Disease Status TERMINATED Phase NA
NCT01434693 Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease Status COMPLETED Phase PHASE1